Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2004
12/22/2004CN1556856A Vaccines from infectious agents
12/22/2004CN1556855A 3-hydroxypropionic acid and other organic compounds
12/22/2004CN1556853A Probiotics lactobacillus casei bacterial strain
12/22/2004CN1556852A Lactic acid producing bacteria for use as probiotic organisms in the human vagina
12/22/2004CN1556851A New strains of lactobacillus paracasei
12/22/2004CN1556850A Product and process for transformation of thraustochytriales microorganisms
12/22/2004CN1556391A Peanut aspergillus flavus anti aflatoxin production preperty identification method
12/22/2004CN1556212A Technology of producing morin aqueous extract and polysaccharide using large scale liquid submerged fermentation process
12/22/2004CN1556209A Anti longicorn Bt gene and its application
12/22/2004CN1556196A Carbofuran pesticide residual degraded bacteria and its produced bacterial agent
12/22/2004CN1556195A Culturing method of sea source bacillus subtilis insect killing activity product and its application
12/22/2004CN1556194A Technology for producing birch brown fungus extract and saccharide using large scale liquid submerged fermentation process
12/22/2004CN1556193A Method of producing edible fungus and its health protection product using malt saccharification liquid
12/22/2004CN1556192A Micropre filtering membrane near natural culturing method for enhancing microorganism cultivation property and its device
12/22/2004CN1181204C Method for preparing 2-hydroxy 4-methylthio butyric acid using nitrilase
12/22/2004CN1181203C Bt gene with high toxicity to Lepidoptera and Coleoptera insects, expression vector and engineering bacteria
12/22/2004CN1181202C Bacillus thuringiensis cryl gene, gene combination and expression vector
12/22/2004CN1181201C LAG-3 splice variants
12/22/2004CN1181192C Bacterial strain for degrading toluene and use thereof
12/22/2004CN1181191C Microorganism producing 5'-inosinic acid and process for producing 5'-inosinic acid using the same
12/22/2004CN1181190C Microorganisms producing L-glutamine and process for producing L-glutamine using the same
12/22/2004CN1181189C Pantemperature streptomycete C-3662 capable of secreting proteinase with fibrinolytic activity
12/22/2004CN1181188C i(bifidobacterium breve) and fermented soy-milk prepared with same
12/22/2004CN1181187C Lipasegenous bacteria, its screening method and industrial application
12/22/2004CN1181186C Deep-layer fermentation process for culturing Brazilian cordyceps mycelia
12/22/2004CN1181185C Expression of proteolytic enzymes in koji mold in presence of carbon sources
12/22/2004CN1181184C Method for producing astaxanthin by cultivating haematococcus pulvialis
12/21/2004US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
12/21/2004US6833490 Involves decreasing the intracellular availability of trehalose-6-phosphate by plant cell transformation with a gene encoding trehalose-6-phosphate phosphatase from E. coli
12/21/2004US6833441 Compositions and methods for generating chimeric heteromultimers
12/21/2004US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004US6833382 Streptogramins and method for preparing same by mutasynthesis
12/21/2004US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004US6833266 Propagation of fungal foods; generate nutrient broth, inoculate with fingus, propagate and recover fungal nutrients
12/21/2004US6833265 Proteases from gram-positive organisms
12/21/2004US6833264 Hyaluronan synthase gene and uses therof
12/21/2004US6833263 AveC gene product from Streptomyces hygroscopicus
12/21/2004US6833261 Such as serine proteases from Bacillus for use in cleaning compositions
12/21/2004US6833252 A DNA sequence that can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals; the vectors are useful in gene mapping and site-directed insertion of genes
12/21/2004US6833135 DNA integration into “Mycobacterium spp.” genome by trans-complementation using a site-specific integration system
12/21/2004US6833134 Immunization of dairy cattle with GapC protein against Streptococcus infection
12/21/2004US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004CA2225436C Method for controlling dreissena species
12/21/2004CA2114788C Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
12/16/2004WO2004108932A1 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a seca protein with increased levels of protein secretion, and method for producing proteins
12/16/2004WO2004108930A1 Genes participating in fgf signal transduction
12/16/2004WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004WO2004108919A1 Biological compositions comprising yeast cells and methods for treatment of cancer
12/16/2004WO2004108915A1 Fusion protein containing a dimerisation domain and an autotransporter domain
12/16/2004WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004WO2004108905A2 Hygienic consolidation of a multi-chamber dosing spray technique and the probiotic use thereof for the application of viable micro-organisms
12/16/2004WO2004108890A2 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
12/16/2004WO2004108609A1 Fermentation media comprising wastewater and use hereof
12/16/2004WO2004108260A2 Devices and methods for biomaterial production
12/16/2004WO2004108155A1 Cells used as carriers for bacteria
12/16/2004WO2004108078A2 Rationally designed antibodies
12/16/2004WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
12/16/2004WO2004094316A3 Bioremediation of petroleum pollution using water-insoluble uric acid as the nitrogen source
12/16/2004WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift
12/16/2004WO2004076659A3 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways
12/16/2004WO2004052297A3 TREATMENT OF HSV-RELATED PATHOLOGIES USING ssDNA
12/16/2004WO2004043881A9 A method to produce succinic acid from raw hydrolysates
12/16/2004WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
12/16/2004WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004WO2003082909A8 Non-ribosomal peptide synthetases and associated biosynthetic genes
12/16/2004WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same
12/16/2004WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
12/16/2004WO2003054152A3 Novel nucleic acids and polypeptides
12/16/2004US20040254363 Genes and snps associated with eating disorders
12/16/2004US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof
12/16/2004US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004US20040254349 Mycobacterial antigens expressed under low oxygen tension
12/16/2004US20040254348 Opiate receptor therapeutic protein/peptides for use in pain relief and management
12/16/2004US20040254346 Human survivin interacting protein 1 (sip-1)
12/16/2004US20040254342 Substrates and assays for beta-secretase
12/16/2004US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors
12/16/2004US20040254235 homoserine lactone derivatives that stimulate or promote the metabolism, growth and/or recovery of microorganisms
12/16/2004US20040254140 Method for selective inactivation of viral replication
12/16/2004US20040254114 Genetic engineering
12/16/2004US20040254105 recombinant vectors and recombinant host cells
12/16/2004US20040253727 Using both insertional and physiochemical means to generate stable, genetic rearrangement in cells; tissue engineering
12/16/2004US20040253713 Ethanol production
12/16/2004US20040253711 Mycobacterial genes down-regulated during latency
12/16/2004US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004US20040253707 Novel cathepsins L-like cysteine protease derived from northern shrimp (Pandalus eous)
12/16/2004US20040253706 Substrates and assays for beta-secretase
12/16/2004US20040253704 Plasmid comprising nucleotide sequences coding poly- gamma -glutamate synthetase for use in developing vaccine for prevention and treatment of bacillus infection
12/16/2004US20040253703 Novel aminopeptidase derived from bacilius licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof
12/16/2004US20040253702 Variants of beta-glucosidases
12/16/2004US20040253700 Expression vector comprising nucleotide sequences coding adenosine triphosphatase for use in improving organismal energy metabolism
12/16/2004US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/16/2004US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression
12/16/2004US20040253695 Using enone reductase to generate optically active intermediates for use in the synthesis of pharmaceuticals
12/16/2004US20040253692 Streptomyces sp. CJPV975652 capable of converting compactin to pravastatin and method for producing pravastatin using the same
12/16/2004US20040253686 Novel human kunitz-type inhibitors and methods relating thereto
12/16/2004US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders
12/16/2004US20040253681 Mitogenic oxygenase regulators
12/16/2004US20040253673 Recombinant botulinum toxins with a soluble C-terminal portion